logo
  

CompuCom Says Certain Of Information Technology Systems Affected By Malware Incident

CompuCom, a managed services provider and wholly owned subsidiary of The ODP Corporation (ODP), said that certain of its information technology systems have been affected by a malware incident. The incident is affecting some of the services that the company provides to certain customers. The company's investigation is in its early stages and remains ongoing.

CompuCom said it has no indication at this time that customers' systems were directly impacted by the incident.

The company immediately took steps to contain it, and engaged leading cybersecurity experts to begin an investigation. It is also communicating with customers to provide updates about the situation and the actions it is taking.

CompuCom noted that it is in the process of restoring customer services and internal operations as quickly and safely as possible. It regrets the inconvenience caused by the interruption and appreciate the ongoing support of customers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT